4-butyrolactone has been researched along with Herpes Simplex Virus Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, H; Ju, J; Song, Y; Wang, X; Zang, R | 1 |
| Chen, F; Figliozzi, RW; Hsia, SV; Kharel, MK; Martin-Caraballo, M; Rochford, K; Waguespack, Y; Zhang, Q | 1 |
2 other study(ies) available for 4-butyrolactone and Herpes Simplex Virus Infection
| Article | Year |
|---|---|
Octyl substituted butenolides from marine-derived
Topics: 4-Butyrolactone; Antiviral Agents; Herpes Simplex; Magnetic Resonance Spectroscopy; Streptomyces | 2021 |
Volatile Organic Compound Gamma-Butyrolactone Released upon Herpes Simplex Virus Type -1 Acute Infection Modulated Membrane Potential and Repressed Viral Infection in Human Neuron-Like Cells.
Topics: 4-Butyrolactone; Animals; Chlorocebus aethiops; Gas Chromatography-Mass Spectrometry; Herpes Simplex; Herpesvirus 1, Human; Humans; Membrane Potentials; Microscopy, Fluorescence; Neurons; Reverse Transcriptase Polymerase Chain Reaction; Vero Cells; Virus Replication | 2016 |